Kura Oncology to Report Fourth Quarter and Full Year 2022
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical
Globe Newswire16-02-2023, 19:46
Policane® Natural Sweetener Found to Have Low Glycemic Index 4-10-2023, 01:06